The business philosophy and tools that revolutionized Toyota could save the ailing drug industry a lot more than just time and money. But is pharma really capable of getting lean?
Adam Farber
Advertisement
Adam Farber is a partner and managing director in BCG's Boston office.
Articles by Adam Farber
Advertisement
Latest Updated Articles
Lean Comes to PharmaPublished: November 18th 2009 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
2
GSK Agrees to $357 Million Exclusive License Agreement for Syndivia’s AntiBody-Drug Conjugate
3
Novartis Enters $12 Billion Definitive Merger Agreement to Acquire Avidity Biosciences
4
Pharmaceutical Executive Daily: New Research Suggests Ozempic May Reduce Biological Age
5
